Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Conditions

• Measles
• Mumps
• Rubella
• Varicella

Interventions

• BIOLOGICAL: MMR Bio-Manguinhos
• BIOLOGICAL: MMR GlaxoSmithKline

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Collaborators

• [object Object]